Effects of selenium supplementation on concurrent chemoradiotherapy in patients with cervical cancer: A randomized, double-blind, placebo-parallel controlled phase II clinical trial

Effects of selenium supplementation on concurrent chemoradiotherapy in patients with cervical cancer: A randomized, double-blind, placebo-parallel controlled phase II clinical trial

ObjectiveSelenium (Se) is an essential trace element and may affect cervical cancer occurrence and progression. The association between selenium supplementation and acute toxic reactions and clinical outcomes in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy...

Full description

Bibliographic Details
Main Authors: Mei Yang, Bo Pei, Qiancheng Hu, Xiaoying Li, Xiping Fang, Xue Huang, Zunjing Yang, Jiaquan Chen, Du He, Guogen Sun, Peng Lv, Li Wang, Zixiong Zhang, Lin Lai, Chuying Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Nutrition
Subjects:
cervical cancer
chemoradiotherapy
clinical trial
hematologic toxicity
selenium
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1094081/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2023.1094081/full

Similar Items